Clinical Improvement After First-Trimester Fetal Whole Pancreas Transplant at a Heterotopic Site in Uncontrolled Diabetes with Varying Degrees of Skin Ulceration of the Leg and Emaciation
Author:
Bhattacharya Niranjan
Publisher
Springer London
Reference22 articles.
1. Ma MT, Leung KK, Tsang KS, Leung PS. Reduced immunogenicity of pancreatic progenitor cells derived from first-trimester human fetal pancreas. Int J Biochem Cell Biol. 2011;43(5):812–20.
2. Brands K, Colvin E, Williams LJ, Wang R, Lock RB, Tuch BE. Reduced immunogenicity of first-trimester human fetal pancreas. Diabetes. 2008;57(3):627–34.
3. Groth CG, Tibell A, Tollemar J, Bolinder J, Östman J, Möller E, Reinholt FP, Korsgren O, Hellerström C, Andersson A. Transplantation of porcine fetal pancreas to diabetic patients. Lancet. 1994;344(8934):1402–4.
4. Sharon AR, Feng C, Mike T, Hammerman MR. Islet cell engraftment and control of diabetes in rats after transplantation of pig pancreatic anlagen. Am J Physiol. 2004;286(4):E502–9.
5. Zhaoyi S, Bernard ET, David AW. Development of human fetal pancreas after transplantation into SCID mice. Cells Tissues Organs. 2001;168:147–57. doi:
10.1159/000047830
.